Author: Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong
Title: Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea Document date: 2020_4_6
ID: 1uwir5b8_15
Snippet: ARDS is partly caused by cytokine storm and host immune responses. 7 Autopsy of patients dying from COVID-19 shows diffuse alveolar damage with exudate and inflammation very similar to those seen in SARS and MERS-CoV infections. 9 Theoretically, systemic corticosteroids may have a role to dampen excessive lung damage due to inflammatory responses. 10 The recent article about risk factors associated with ARDS and death among COVID-19 patients show.....
Document: ARDS is partly caused by cytokine storm and host immune responses. 7 Autopsy of patients dying from COVID-19 shows diffuse alveolar damage with exudate and inflammation very similar to those seen in SARS and MERS-CoV infections. 9 Theoretically, systemic corticosteroids may have a role to dampen excessive lung damage due to inflammatory responses. 10 The recent article about risk factors associated with ARDS and death among COVID-19 patients showed that treatment with methylprednisolone might be beneficial to reduce the risk of death for patients developing ARDS. 11 However, corticosteroids are also thought to inhibit proper immune responses and viral clearance and delay antibody production. 12,13
Search related documents:
Co phrase search for related documents- alveolar damage and cytokine storm: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alveolar damage and death risk: 1, 2, 3, 4, 5, 6, 7
- alveolar damage and excessive lung damage: 1
- alveolar damage and host immune response: 1, 2, 3, 4, 5
- alveolar damage and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alveolar damage and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- alveolar damage and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody production and cytokine storm: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- antibody production and death risk: 1, 2
- antibody production and host immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antibody production and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody production and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- antibody production and lung damage: 1
- ARDS develop and cytokine storm: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- ARDS develop and death risk: 1, 2, 3, 4, 5, 6, 7, 8
- ARDS develop and host immune response: 1, 2
- ARDS develop and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ARDS develop and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- ARDS develop and lung damage: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date